I don’t have live browsing capability, so I can’t pull today’s headlines directly. But I can help you get a solid, up-to-date briefing in a few ways:
Options for getting current life sciences news
- You provide 5–7 links or topics from today, and I’ll write concise summaries with key takeaways and potential impact.
- I give you a ready-to-use daily/weekly digest template (top regulatory/approval news, clinical trial highlights, funding and partnerships, and M&A) that you can fill in from your usual sources.
- I can give you a high-level briefing on current trends and what kinds of headlines are most likely to be in circulation today (e.g., new FDA/EMA approvals, Phase 3 results, major funding rounds, strategic partnerships, policy/regulatory shifts, and big biotech M&A).
Best sources to follow for real-time updates
- Regulatory and policy: FDA, EMA, PMDA announcements; Congress and health policy news
- News outlets: Reuters, Bloomberg, CNBC Health, Stat News, Endpoints News, FierceBiotech, BioPharmaDive
- Scientific/clinical: Nature News, Science News, ClinicalTrials.gov updates, company press releases
- Market/activity: NASDAQ biotech movers, company investor days, major deal announcements
If you’d like, tell me:
- Your focus (biotech startups, big pharma, medtech, oncology, rare diseases, AI in drug discovery, etc.)
- Geographic scope (US, Europe, global)
- How many headlines or summaries you want (e.g., 5–10 items)
Or paste today’s headlines or links, and I’ll summarize them for you right away.